ciated with moderate MR. After relief of congestive heart failure, 24-h Holter monitoring showed that total ventricular activity was 171,360 beats/day at a mean heart rate of 119 beats/min, even on methyldigoxin and verapamil.Because of the drug-refractory atrial fibrillation, we decided to use AVN ablation and pacing therapy, but because we were worried that there might be post-procedural deterioration of the MR we elected to use direct His-bundle pacing therapy, which is an advanced but still investigational technique, after written informed consent was given. A hexapolar catheter with 2-mm interelectrode spacing was introduced via a femoral vein and advanced near the AV septum superior to the tricuspid valve. Subsequent mapping and localization of the His-bundle was done in biplane fluoroscopic projections. The catheter was positioned to record the largest bipolar His-bundle potential, and an attempt was made to capture and pace the His-bundle. Next, the ablation catheter with a 4-mm distal electrode (EP Technologies Inc, San Jose, CA, USA) was positioned in the compact AVN area. Radiofrequency energy was delivered, starting posteriorly and advancing anteriorly toward the area of the largest His-bundle potential recording site, until complete AV block was obtained ( Fig 2C). After the second radiofrequency application to the compact AVN, complete AV block was produced and junctional escape rhythm emerged at a mean heart rate of 40 beats/min (Fig 2A). The successful ablation site had a large atrial potential, small ventricular potential, and tiny His-bundle potential, which implied compact AVN ablation, not Hisbundle ablation.Acute hemodynamic assessment using a Swan-Ganz catheter and LV cannulation compared the hemodynamic improvement between 3 pacing sites: the RV outflow tract (RVOT), RV apex (RVA), and His-bundle area. Data obtained were as follows. LV end-diastolic pressure (LVEDP) was 14 mmHg before ablation and after AVN ablation, LVEDP decreased to 11 mmHg during RVA pacing, 9 mmHg during RVOT pacing, and 7 mmHg during Hisbundle pacing. Mean pulmonary capillary wedge pressure trioventricular node (AVN) ablation followed by permanent pacemaker implantation has proven very effective in controlling ventricular rates in patients with drug-refractory atrial fibrillation 1-4 and most patients show a marked improvement in cardiac performance and quality of life. This potential benefit seems to be greatest in patients with depressed left ventricular (LV) function prior to the procedure. 2 However, hemodynamic deterioration in relation to worsening mitral regurgitation (MR) can occur in a small number of patients following AVN ablation and pacing therapy 5,6 and those with moderate MR prior to the ablation seem prone to this complication. 5,7 High right ventricular (RV) septal pacing produces shorter QRS duration and better chronic LV function than RV apical pacing in patients with mild to moderate LV dysfunction and chronic atrial fibrillation after AVN ablation, [8][9][10][11] but direct His-bundle pacing pro...